Azelastine

Azelastine

SCHEMBL6886545

CC(O)C(=O)O.CN1CCC[C@H](n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Azelastine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 18/20 0.84
ADRA1A P35348 18/20 0.84
ADRA1B P35368 18/20 0.84
HRH3 Q9Y5N1 11/20 0.84
KCNH2 Q12809 8/20 0.84
ADRA2A P08913 2/20 0.84
CHRM1 P11229 2/20 0.84
ADRA2B P18089 2/20 0.84
HTR2A P28223 2/20 0.84
DRD3 P35462 2/20 0.84
ABCB1 P08183 2/20 0.84
CHRM2 P08172 1/20 0.84
ADRB1 P08588 1/20 0.84
CYP2D6 P10635 1/20 0.84
GABRA1 P14867 1/20 0.84
ADRA2C P18825 1/20 0.84
SLC6A2 P23975 1/20 0.84
HTR2C P28335 1/20 0.84
SLC6A4 P31645 1/20 0.84
OPRM1 P35372 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azelastine SCHEMBL6886542 1.00 ADRA1A (0.84) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL6887622 0.93 ADRA1A (0.91) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL6887627 0.93 ADRA1A (0.91) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL17223862 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL4239 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL4240 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL30910968 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL4433245 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL17803891 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2
Azelastine SCHEMBL29370712 0.92 ADRA1A (1.00) ADRA1AHRH1ADRA1BHRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6017909-A Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect ASTA PHARMA AG (DE) 2000-01-25 US claimed
US-5998403-A Salts of azelastine having improved solubility useful at providing a cytoprotective effect ASTA PHARMA AKTIENGESELLSCHAFT (DE) 1999-12-07 US claimed
US-5859003-A ANTIALLERGENS, ANTIASTHMATICS ASTA PHARMA AKTIENGESELLSCHAFT (DE) 1999-01-12 US claimed
US-5086050-A With acetic, gluconic, lactic or malic acids, administering ASTA PHARMA AG (DE) 1992-02-04 US claimed
US-20040198828-A1 Using ketotifen and pheniramine OPHTHALMIC RESEARCH ASSOCIATES, INC. 2004-10-07 US disclosed
WO-2004069157-A2 COMBINATIONAL USE OF LONG-ACTING AND SHORT-ACTING ANTI-HISTAMINES FOR OCULAR ALLERGIES OPHTHALMIC RESEARCH ASSOCIATES, INC. (US) 2004-08-19 WO disclosed
US-6017909-A Salts of azelastine having improved solubility effective at treating psoriasis and providing a cytoprotective effect ASTA PHARMA AG (DE) 2000-01-25 US disclosed
US-5998403-A Salts of azelastine having improved solubility useful at providing a cytoprotective effect ASTA PHARMA AKTIENGESELLSCHAFT (DE) 1999-12-07 US disclosed
US-5859003-A ANTIALLERGENS, ANTIASTHMATICS ASTA PHARMA AKTIENGESELLSCHAFT (DE) 1999-01-12 US disclosed
US-5086050-A With acetic, gluconic, lactic or malic acids, administering ASTA PHARMA AG (DE) 1992-02-04 US disclosed